· Weekly signal · RVMD
Revolution Medicines Inc (RVMD) adds 5.9% as biotech strength holds in weekly context
The oncology drug developer’s 52-week weekly price path remains firm, though the latest turnover came in below its recent average.
Revolution Medicines Inc (RVMD) rose 5.9% for the week ended June 19, closing at 162.99 USD. The move kept the Nasdaq-listed biotechnology name in an active trend state within a weekly price path over 52 weeks.
The broader setup is still strong but not one-sided. The shares are up 7.5% over four weeks and 76.2% over twelve weeks, while latest weekly volume of 11.6 million shares was below the 13-week average of 15.0 million. Market Dynamics at 0.92 adds confirmation, with Relative Strength at 64.1.